title: Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate.
authors.affiliation: Spanish Lung Cancer Group, Medical Oncology Unit, Germans Trias i Pujol University Hospital, Badalona, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Rosell
authors.forename: J
authors.initials: J
authors.lastname: Gómez-Codina
authors.forename: A
authors.initials: A
authors.lastname: Anton
authors.forename: J J
authors.initials: JJ
authors.lastname: Sánchez
authors.forename: C
authors.initials: C
authors.lastname: Vadell
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D015251:Epirubicin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male
chemical_list: D015251:Epirubicin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D002945:Cisplatin